Oral Liquid
Home | Our Products
Our Products
NO. | GENERIC NAME | COMPOSITION | |||
1- | Paracetamol Paediatric Oral Suspension I.P. 125 mg | Each 5 ml contains: Paracetamol IP 125 mg In a flavoured syrups base q.s. Colour: Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) | |||
2- | Paracetamol Paediatric Oral Suspension I.P. 250 mg | Each 5 ml contains: Paracetamol IP 250 mg In a flavoured syrups base q.s. Colour: Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) | |||
3- | Cetirizne Syrup I.P. 5 mg | Each 5 ml contains : Cetirizne Hydrocloride IP 5 mg Pleasantly Flavoured syrups base q.s. colour : sunset yellow FCF | |||
4- | Lactulose solution U.S.P. 10 mg | Each 15 ml contains : Lactulose Concentrate U.S.P. eq. to Lactulose 10 mg In a palatable non-syrupy base q.s. Colour : Caramel I.P. | |||
5- | Magaldrate & Simethicone Oral Suspension U.S.P. | Each 5 ml Contains : Magaldrate IP 10 mg eq. to Anhydrous Magaldrate 400 mg Simethicone IP 50 mg In a flavoured non-syrupy base q.s. Colour: Brilliant Blue FCF & Tartrazine | |||
6- | Ofloxacn Oral Suspension I.P. 100 mg | Each 5 ml Contains: Ofloxacin IP 100 mg In a flavoured syrupy base q.s. Colour: Sunset Yellow FCF | |||
7- | Cyproheptadine Hydrochloride Syrup I.P. 2 mg | Each 5 ml contains : Cyproheptadine Hydrochloride IP eq. to Anhydrous Cyproheptadine Hydrochloride 2 mg In a flavoured syrupy base q.s. Colour : Sunset Yellow FCF | |||
8- | Albendazole Oral Suspension I.P. 400 mg | Each 10 ml contains : Albendazole IP 400 mg In a flavoured non-syrupy base q.s. Colour : Sunset Yellow FCF | |||
9- | Ofloxacin Oral Suspension I.P. 50 mg | Each 5 ml contains : Ofloxacin IP 50 mg In a flavoured syrupy base q.s. Colour : Sunset Yellow FCF | |||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
10- | Potassium Citrate,Magnesium Citrate & | Each 5 ml contains : | |||
Pyridoxine Hydrochloride Oral Solution | Potassium Citrate | IP | 1100 | mg | |
Magnesium Citrate | U.S.P. | 375 | mg | ||
Pyridoxine Hydrochloride | IP | 20 | mg | ||
In a flavoured non-syrupy base | q.s. | ||||
Colour : Caramel I.P. | |||||
Appropriate overages of vitamin added to | |||||
compensate for loss on storage | |||||
11- | Ferrous Ascorbate & Folic Acid Oral Suspension | Each 5 ml contains : | |||
Ferrous Ascorbate | 30 | mg | |||
eq. to elemental iron | |||||
For Therapeutic Use | Folic Acid | IP | 550 | mg | |
In a flavoured suspension base | q.s. | ||||
Colour : Caramel I.P. | |||||
Appropriate overages of vitamin added to compensate for | |||||
loss on storage | |||||
12- | Cholecalciferol Oral Drops 800 I.U. | Each ml contains : | |||
Cholecalciferol I.P. ( As Stabilized) | 800 | IU | |||
In a flavoured non-syrupy base | q.s. | ||||
Appropriate overages of vitamin added to compensate for | |||||
loss on storage | |||||
13- | Azithromycin Oral Suspension 100 mg | Each 5 ml contains : | |||
Azithromycin Dihydrate | IP | 100 | mg | ||
Anhydrous Azithromycin | |||||
In a flavoured syrupy base | q.s. | ||||
Colour : Quinoline Yellow | |||||
14- | Azithromycin Oral Suspension 100 mg I.P. | Each 5 ml contains : | |||
Azithromycin Dihydrate | IP | 200 | mg | ||
Anhydrous Azithromycin | |||||
In a flavoured syrupy base | q.s. | ||||
Colour : Quinoline Yellow | |||||
15- | Cholecalciferol Oral Drops 400 I.U. | Each ml contains : | |||
Cholecalciferol I.P. ( As Stabilized) | 400 | IU | |||
In a flavoured non-syrupy base | q.s. | ||||
Colour : Sunset Yellow FCF | |||||
Appropriate overages of vitamin added to | |||||
For Therapeutic Use | compensate for loss on storage | ||||
16- | Ferrous Sulphate and Folic Acid Syrup I.P. | Each 5 ml. syrup contains: | |||
Ferrous Sulphate | IP | ||||
eq. to elemental Iron | 100 | mg | |||
Folic Acid | 0.5 | mg | |||
In a flavoured Syrupy Base | |||||
Colour : Caramel | |||||
17- | Paracetamol Paediatric Syrup I.P. | Each 5 ml. syrup contains: | |||
Paracetamol | IP | 125 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colours : Sunset Yellow | |||||
18- | Phenylephrine Hydrochloride and | Each 1 ml. contains: | |||
Chlorpheniramine Maleate Drops I.P. | Phenylephrine Hydrochloride | IP | 5 | mg | |
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Ponceau 4R | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
19- | Phenylephrine Hydrochloride and | Each 5 ml. contains: | |||
Chlorpheniramine Maleate Drops I.P. | Phenylephrine Hydrochloride | IP | 5 | mg | |
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Ponceau 4R | |||||
20- | Piperazine Citrate Syrup I.P. | Each 5 ml. syrup contains: | |||
Piperazine Citrate | IP | 125 | mg | ||
eq. to Piperazine Hydrate | 100 | mg | |||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Sunset Yellow | |||||
21- | Promethazine Hydrochloride Syrup I.P. | Each 5 ml. syrup contains: | |||
Promethazine Hydrochloride | IP | 5 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Caramel | |||||
22- | Hydroxyzine Oral Solution I.P. | Each 5 ml. syrup contains: | |||
Hydroxyzine Hydrochloride | IP | 10 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
colour: Ponceau 4R | |||||
23- | Hydroxyzine Oral Solution I.P. | Each 5 ml. syrup contains: | |||
Hydroxyzine Hydrochloride | IP | 25 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
colour: Tartrazine | |||||
24- | Ambroxol Hydrochloride, Salbulamol, | Each 5 ml. syrup contains: | |||
Guaiphenesin and Menthol Syrup | Ambroxol Hydrochloride | IP | 15 | mg | |
Salbutamol | 1 | mg | |||
Guaiphenesin | IP | 50 | mg | ||
Menthol | 1 | mg | |||
In a flavoured Syrupy Base | q.s. | ||||
colour: Ponceau 4R | |||||
25- | Codeine Phosphate and Syrup I.P. | Each 5 ml. syrup contains: | |||
Codeine Phosphate | IP | 10 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
colour: Ponceau 4R | |||||
26- | Desloratadine, Ambroxol, Guiphenasine and | Each 5 ml. syrup contains: | |||
Menthol Syrup | Desloratadine | IP | 2.5 | mg | |
Ambroxol Hydrochloride | 30 | mg | |||
Guaiphenesin | IP | 50 | mg | ||
Menthol | 1 | mg | |||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Sunset Yellow | |||||
27- | Levocetrizine Hydrochloride and Ambroxol | Each 5 ml. syrup contains: | |||
Hydrochloride Syrup | Levocetrizine Hydrochloride | IP | 2.5 | mg | |
Ambroxol Hydrochloride | IP | 30 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Sunset Yellow | |||||
28- | Levocetrizine Hydrochloride and Ambroxol | Each 5 ml. syrup contains: | |||
Hydrochloride Syrup | Levocetrizine Hydrochloride | IP | 5 | mg | |
Ambroxol Hydrochloride | IP | 30 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour :Erythrosine | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
29- | Phenylephrine, Chlorpheniramine maleate, | Each 5 ml. syrup contains: | |||
Paracetamol, Sodium Citrate and Menthol | Phenylephrine Hydrochloride | IP | 5 | mg | |
Syrup | Chlorphenaramine Maleate | 0.5 | mg | ||
Paracetamol | IP | 125 | mg | ||
Sodium Citrate | 60 | mg | |||
Menthol | 1 | mg | |||
In a flavoured Syrupy Base | q.s. | ||||
colour: Tartrazine | |||||
30- | Doxyphylline and Terbutaline Syrup | Each 5 ml. syrup contains: | |||
Doxyphylline | IP | 2 | mg | ||
Terbutaline | IP | 120 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour : Sunset Yellow | |||||
31- | Levodropropizine and Chlorpheniramine | Each 5 ml. syrup contains: | |||
Maleate Syrup | Levodropropizine Eur. Ph. | 30 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
colour: Ponceau 4R | |||||
32- | Citicoline and Piracetam Syrup | Each 5 ml. syrup contains: | |||
Citicoline Sodium | IP | ||||
eq. to Citicoline | 500 | mg | |||
Piracetam | IP | 400 | mg | ||
In a flavoured Syrupy Base | q.s. | ||||
Colour :Erythrosine | |||||
33- | Ambroxol, Terbutaline, Guaiphenesin and | Each 5 ml contains: | |||
Menthol Syrup | Ambroxol Hydrochloride | IP | 15 | mg | |
Terbutaline Sulphate | IP | 1.25 | mg | ||
Guaiphenesin | IP | 50 | mg | ||
Menthol | 2.5 | mg | |||
In a palatable syrup base | |||||
Colour: Ponceau 4R | |||||
Dose :As directed by the physician. | |||||
34- | Dextromethorphan and Chlorphenaramine Syrup | Each 5 ml contains: | |||
Dextromethorphan Hydrobromide | IP | 10 | mg | ||
Chlorphenaramine Maleate | IP | 2 | mg | ||
In a palatable syrup base | |||||
Colour: Ponceau 4R | |||||
Dose :As directed by the physician. | |||||
35- | Doxyphylline and Terbutaline Syrup | Each 5 ml contains: | |||
Doxyphylline | IP | 120 | mg | ||
Terbutaline Sulphate | IP | 2 | mg | ||
In a palatable syrup base | |||||
Colour :Sunset Yellow FCF | |||||
Dose :As directed by the physician. | |||||
36- | Ambroxol, Terbutaline and Guaiphenesin Syrup | Each 10 ml contains: | |||
Ambroxol Hydrochloride | IP | 30 | mg | ||
Terbutaline Sulphate | IP | 2.5 | mg | ||
Guaiphenesin | IP | 100 | mg | ||
In a palatable mentholated syrup base | |||||
Colour :Sunset Yellow FCF | |||||
Dose :As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
37- | Zinc Sulphate Oral Solution IP | Each 5 ml contains: | |||
Zinc Sulphate Monohydrate | IP | 20 | mg | ||
eq. to elemental Zinc | IP | 7.5 | mg | ||
In a palatable syrup base | |||||
Colour :Sunset Yellow FCF | |||||
Dose :As directed by the physician. | |||||
38- | Citicoline and Piracetam Syrup | Each 5 ml contains: | |||
Citicoline Sodium | IP | ||||
eq. to Citicoline | 500 | mg | |||
Piracetam | IP | 400 | mg | ||
In a palatable syrup base | |||||
Colour :Erythrosine | |||||
Dose :As directed by the physician. | |||||
39- | Piracetam Syrup | Each 5 ml contains: | |||
Piracetam | IP | 500 | mg | ||
In a palatable syrup base | |||||
Colour :Erythrosine | |||||
Dose :As directed by the physician. | |||||
40- | Sucralfate Suspension 1 gm | Each 10 ml contains: | |||
Sucralfate | IP | 1 | gm | ||
In a suspension base | |||||
Colour : Quinoline Yellow WS | |||||
Dose :As directed by the physician. | |||||
41- | Sodium picosulfate oral Solution BP | Each 5 ml contains: | |||
Sodium picosulfate | BP | 5 | mg | ||
In a flavoured Syrupy Base | |||||
Colour : Tartrazine & Brilliant blue FCF | |||||
Dose :As directed by the physician. | |||||
42- | Fexofenadine Suspension 30 mg | Each 5 ml contains: | |||
Fexofenadine Hydrochloride | IP | 30 | mg | ||
In a flavoured Suspension base | |||||
Colour : Sunset Yellow FCF & Titanium Dioxide IP | |||||
Dose :As directed by the physician. | |||||
43- | Cyproheptadine Hydrochloride and Tricholine | Each 5 ml contains: | |||
Citrate Syrup | Cyproheptadine Hydrochloride | IP | 2 | mg | |
Tricholine Citrate | 275 | mg | |||
In a flavoured syrupy base | |||||
Colour : Caramel | |||||
Dose :As directed by the physician. | |||||
44- | Levocetirizine Hydrochloride and Montelukast Syrup | Each 5 ml contains: | |||
Levocetirizine Hydrochloride | IP | 2.5 | mg | ||
Montelukast Sodium | IP | ||||
eq. to Montelukast | 4 | mg | |||
In a flavoured syrupy base | |||||
Colour : Tartrazine | |||||
Dose :As directed by the physician. | |||||
45- | Ofloxacin Suspension IP 50 mg | Each 5 ml contains: | |||
Ofloxacin | IP | 50 | mg | ||
In a suspension base | |||||
Colour : Tartrazine | |||||
Dose :As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
46- | Ranitidine Oral solution IP 75 mg | Each 5 ml contains: | |||
Ranitidine Hydrochloride | IP | ||||
Ranitidine Hydrochloride | 75 | mg | |||
In a flavoured syrupy base | |||||
Colour : Quinoline Yellow WS | |||||
Dose :As directed by the physician. | |||||
47- | Sucralfate and Oxetacaine Gel | Each 10 ml contains: | |||
Sucralfate | IP | 1 | gm | ||
Oxetacaine | BP | 20 | mg | ||
n a flavoured Suspension base | |||||
Colour : Quinoline Yellow WS | |||||
Dose :As directed by the physician. | |||||
48- | Pepsin and Fungal Diatase Syrup | Each 5 ml contains: | |||
Pepsin (1:3000) | 10 | mg | |||
Fungal Diatase (1:1200) | 50 | mg | |||
In a flavoured syrupy base | |||||
Colour : Caramel | |||||
Dose :As directed by the physician. | |||||
Appropriate Overages added. | |||||
49- | Sodium Feredetate Oral Solution BP | Each 5 ml contains: | |||
Sodium feredetate | BP | 231 | mg | ||
Eq. to elemental Iron | 33 | mg | |||
In a flavoured syrupy base | |||||
Dose: As directed by the physician | |||||
50- | Chlorpheniramine Maleate and Phenylephrine | Each 5 ml conatins: | |||
Hydrochloride Syrup IP | Chlorpheniramine Maleate | IP | 2 | mg | |
Phenylephrine Hydrochloride | IP | 5 | mg | ||
In a flavoured syrupy base | |||||
Colour:-Ponceau 4R | |||||
Dose: As directed by the physician | |||||
51- | Levosalbutamol Syrup | Each 5 ml conatins: | |||
Levosalbutamol Sulphate | IP | ||||
Eq. to Levosalbutamol | 1 | mg | |||
In a flavoured syrupy base | |||||
Colour :Sunset Yellow FCF | |||||
Dose :As directed by the physician. | |||||
52- | Levosalbutamol, Ambroxol and Guaiphenesin | Each 5 ml conatins: | |||
Syrup | Ambroxol Hydrochloride | IP | 15 | mg | |
Levosalbutamol Sulphate | IP | ||||
Eq. to Levosalbutamol | 0.5 | mg | |||
Guaiphenesin | IP | 50 | mg | ||
In a flavoured syrupy base | |||||
Colour : Tartrazine | |||||
Dose :As directed by the physician. | |||||
53- | Levosalbutamol, Ambroxol and Guaiphenesin | Each 5 ml conatins: | |||
Syrup | Ambroxol Hydrochloride | IP | 30 | mg | |
Levosalbutamol Sulphate | IP | ||||
Eq. to Levosalbutamol | 1 | mg | |||
Guaiphenesin | IP | 50 | mg | ||
In a flavoured syrupy base | |||||
Colour : Tartrazine | |||||
Dose :As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
54- | Ambroxol, Terbutaline and Guaiphenesin | Each 5 ml conatins: | |||
Syrup | Ambroxol Hydrochloride | IP | 15 | mg | |
Terbutaline Sulphate | IP | 1.25 | mg | ||
Guaiphenesin | IP | 50 | mg | ||
In a flavoured syrupy base | |||||
Colour : Ponceau 4R | |||||
Dose :As directed by the physician. | |||||
55 | Levocetirizine Hydrochloride Syrup | Each 5 ml contains: | |||
Levocetirizine Hydrochloride | IP | 5 | mg | ||
In a flavoured syrupy base | |||||
Dose :As directed by the physician. | |||||
56 | Linezolid Oral Suspension 100 mg | Each 5 ml suspension after reconstitution contains: | |||
Linezolid | IP | 100 | mg | ||
In a palatable base | q.s. | ||||
Dose : As directed by the physician. | |||||
57 | Deflazacort Oral Suspension 6 mg | Each 5 ml contains: | |||
Deflazacort | 6 | mg | |||
In a flavoured suspension base | |||||
Dose : As directed by the physician. | |||||
58 | Zinc Sulphate Oral Solution IP | Each 5 ml contains: | |||
Zinc Sulphate Monohydrate | IP | 54.90 | mg | ||
eq. to elemental Zinc | 20 | mg | |||
In a flavoured syrupy base | |||||
Colour : Ponceau 4R | |||||
Dose :As directed by the physician. | |||||
59 | Zinc Gluconate Oral Solution | Each 5 ml contains: | |||
Zinc Gluconate | USP | ||||
eq. to elemental Zinc | 20 | mg | |||
In a flavoured syrupy base | |||||
Colour : Ponceau 4R | |||||
Dose :As directed by the physician. | |||||
60 | Lactulose Solution USP | Each 5 ml contains: | |||
Lactulose Concentrate | USP | 3.33 | mg | ||
In a palatable base | |||||
Colour : Caramel IP | |||||
Dose :As directed by the physician. | |||||
61 | Aluminium, Magnesium and | Each 5 ml Suspension contains: | |||
Simethicone Oral Suspension IP | Dried Aluminium Hydroxide | IP | 250 | mg | |
Magnesium Hydroxide | IP | 250 | mg | ||
Simethicone Emulsion | IP | ||||
eq. to Simethicone | 50 | mg | |||
In a flavoured Suspension Base | |||||
Colour :Erythrosine | |||||
Dose :As directed by the physician. | |||||
62 | Aluminium, Magnesium and | Each 5 ml Suspension contains: | |||
Simethicone Oral Suspension IP | Dried Aluminium Hydroxide | IP | 250 | mg | |
Magnesium Hydroxide | IP | 250 | mg | ||
Simethicone Emulsion | USP | ||||
eq. to Simethicone | 50 | mg | |||
In a flavoured Suspension Base | |||||
Colour :Erythrosine | |||||
Dose :As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
63 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains: | |||
Disodium Hydrogen Citrate | BP | 1.40 | gm | ||
In a palatable base | |||||
Colour: Tartrazine | |||||
Dose :As directed by the physician. | |||||
64 | Triclofos oral Solution IP | Each 5 ml contains: | |||
Triclofos Sodium | IP | 500 | mg | ||
in a palatable base | |||||
Colour: Sunset yellow FCF | |||||
Dose :As directed by the physician. | |||||
65 | Sodium Picosulfate, Liquid Paraffin and | Each 5 ml contains: | |||
Milk of magnesia Suspension | Sodium Picosufate | BP | 3.33 | mg | |
Liquid Paraffin | IP | 1.25 | mg | ||
Milk of Magnesia | IP | 3.75 | ml | ||
In a flavoured suspension base | |||||
Colour: Carmosine and ponceau 4R | |||||
Dose: As directed by the physician. | |||||
66 | Ondansetron Oral Solution IP 4 mg | Each 5 ml contains contains: | |||
Ondansetron Hydrochloride | IP | ||||
eq. to Ondansetron | 4 | mg | |||
In a palatable base | |||||
Colour : Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
67 | Hydroxyzine Oral Solution IP | Each 5 ml contains: | |||
Hydroxyzine Hydrochloride | IP | 10 | mg | ||
In a palatable syrup base | |||||
Dose: As directed by the physician. | |||||
68 | Dil Oil, Fennel Oil with Simethicone Drops | Each ml contains: | |||
Dil Oil | BP | 0.005 | ml | ||
Fennel Oil | USP | 0.0007 | ml | ||
Simethicone Emulsion | USP | ||||
eqv to Simethicone | 40 | mg | |||
In a palatable base | qs | ||||
Dose: As directed by the physician. | |||||
69 | Ferric Ammonium Citrate, Folic Acid & | Each 15 ml contains: | |||
Vitamin B12 Suspension | Ferric Ammonium Citrate | IP | 160 | mg | |
eqv to elemental Iron | 32.8 | mg | |||
Folic Acid | IP | 1 | mg | ||
Vitamin B12 | IP | 7.5 | mcg | ||
In a palatable base | |||||
Colour : Caramel & Erythrosine | |||||
Dose: As directed by the physician. | |||||
70 | Levocetirizine Hydrochloride Syrup 5 mg/5 ml | Each 5 ml contains: | |||
Levocetirizine Hydrochloride | IP | 5 | mg | ||
In a palatable base | |||||
Dose: As directed by the physician. | |||||
71 | Sucralfate and Oxetacaine Suspention | Each 10 ml contains: | |||
Sucralfate | IP | 500 | mg | ||
Oxetacaine | BP | 10 | mg | ||
In a palatable base | |||||
Colour : Quinoline Yellow WS | |||||
Dose: As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
72 | Sucralfate, Oxetacaine and Simethicone | Each 10 ml contains: | |||
Oral Suspension | Sucralfate | IP | 500 | mg | |
Oxetacaine | BP | 10 | mg | ||
Simethicone Emulsion | USP | ||||
eq. to Simethicone | 50 | mg | |||
In a palatable base | |||||
Colour : Erythrosine | |||||
Dose: As directed by the physician. | |||||
73 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each ml contains: | |||
Levosalbutamol Sulphate | IP | ||||
eq. to Levosalbutamol | 0.25 | mg | |||
Ambroxol | BP | 7.50 | mg | ||
Guaophenesin | USP | 12.5 | mg | ||
In a palatable base | |||||
Colour : Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
74 | Paracetamol,Phenylephrine hydrochloride and Chlorpheniramine maleate Suspension | Each 5 ml conrains: | |||
Paracetamol | IP | 250 | mg | ||
Phenylephrine hydrochloride | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a mentholated flavoured suspension base | |||||
Colour : Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
75 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: | |||
Paracetamol | IP | 125 | mg | ||
Mefenamic Acid | IP | 50 | mg | ||
In a mentholated flavoured suspension base | |||||
Colour : Tartrazine | |||||
Dose: As directed by the physician. | |||||
76 | Dextromethorphan Hydrochloride, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | Each 5 ml conrains: | |||
Dextromethorphan Hydrobromide | IP | 10 | mg | ||
Phenylephrine hydrochloride | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a mentholated flavoured syrup base | |||||
Colour: Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
77 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: | |||
Paracetamol | IP | 250 | mg | ||
Mefenamic Acid | IP | 100 | mg | ||
In a mentholated flavoured suspension base | |||||
Colour : Tartrazine | |||||
Dose: As directed by the physician. | |||||
78 | Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml contains: | |||
levodropropizine | BP | 30 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a mentholated flavoured syrup base | |||||
Colour : Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
79 | Levocloperastine Fendizoate Oral Suspension | Each 5 ml suspension contains: | |||
Levocloperastine Fendizoate | 35.40 | mg | |||
eqv. To Levocloperastine Hydrochloride | 20.00 | mg | |||
In a flavoured Suspension Base | |||||
Colour :Erythrosine | |||||
Dose :As directed by the physician. | |||||
80 | Phenylephrine Hydrochloride and Chlorpheniramine | Each ml contains: | |||
maleate Drops | Phenylephrine hydrochloride | IP | 5 | mg | |
Chlorpheniramine Maleate | IP | 2 | mg | ||
In a mentholated flavoured syrup base | |||||
Colour: Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
81 | Aluminium, Magnesium & Simethicone Oral | Each 10 ml contains: | |||
Suspension IP | Dried Aluminium Hydroxide | IP | 250 | mg | |
Magnesium Hydroxide | IP | 250 | mg | ||
Simethicone Emulsion | USP | ||||
Eqv. To Simethicone | 50 | mg | |||
In a Palatable Suspension base | |||||
Colour: Erythrosine | |||||
Dose: As directed by the physician. | |||||
82 | Ondansetron Oral Solution IP | Each 5 ml contains: | |||
Ondansetron Hydrochloride | IP | ||||
Eqv. To Ondanstron | 2 | mg | |||
In a flavoured syrup base | |||||
Colour: Ponceau 4R | |||||
Dose: As directed by the physician. | |||||
83 | Codeine Phosphate & Chlorpheniramine Maleate | Each 5 ml contains: | |||
Syrup | Codeine Phosphate | IP | 10 | mg | |
Chlorpheniramine Maleate | IP | 4 | mg | ||
In a flavoured syrup base | |||||
Colour : Carmoisine & Sunset Yellow FCF | |||||
Dose : As directed by the physician. | |||||
84 | Codeine Phosphate & Triprolidine Hydrochloride | Each 5 ml contains: | |||
Syrup | Codeine Phosphate | IP | 10 | mg | |
Triprolidine Hydrochloride | IP | 1.25 | mg | ||
In a flavoured syrup base | |||||
Colour : Carmoisine | |||||
Dose: As directed by the physician. | |||||
85 | Levetiracetam Oral Solution IP 500mg/5ml | Each 5 ml contains: | |||
Levetiracetam | IP | 500 | mg | ||
Flavoured Syrupy Base | |||||
Colour : Sunset Yellow FCF | |||||
Dosage : As directed by the Physician. | |||||
86 | Levetiracetam Oral Solution IP 100mg/ml | Each ml contains: | |||
Levetiracetam | IP | 100 | mg | ||
Flavoured Syrupy Base | |||||
Colour : Sunset Yellow FCF | |||||
Dosage : As directed by the Physician. | |||||
87 | Racecadotril Suspension 10mg/5ml | Each 5 ml contains: | |||
Racecadotril | IP | 10 | mg | ||
Flavoured Syrupy base | |||||
Colour : Sunset yellow FCF | |||||
Dosage: As directed by the Physician | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
88 | Levosolbutamol,Ambroxol and guaiphensin Syrup | Each 5 ml contains: | |||
Levosalbutamol Sulphate | |||||
eqv. To levosolbutamol | IP | 1 | mg | ||
Ambroxol Hydrochloride | IP | 15 | mg | ||
Guaiphensin | IP | 50 | mg | ||
Flavoured Syrupy base | |||||
Colour : Tartrazine | |||||
Dosage: As directed by the Physician | |||||
89 | Levosolbutamol,Ambroxol and guaiphensin Drops | Each ml contains: | |||
Levosalbutamol Sulphate | |||||
eqv. To levosolbutamol | IP | 0.25 | mg | ||
Ambroxol Hydrochloride | IP | 7.5 | mg | ||
Guaiphensin | IP | 12.5 | mg | ||
Flavoured Syrupy base | |||||
Colour : Tartrazine | |||||
Dosage: As directed by the Physician | |||||
90 | Diphenhydramine,Codeine,Sodium Citrate & | Each 5ml dispensry cup contains: | |||
Menthol Syrup | Diphenhydramine Hydrochloride | BP | 13.50 | mg | |
(FOR EXPORT) | Codeine Phosphate | BP | 11.95 | mg | |
Sodium Citrate | BP | 54.4 | mg | ||
Menthol | BP | 1.1 | mg | ||
Flavoured Syrupy Base | |||||
Colour : Approved colours used | |||||
Dosages : As directed by the physician. | |||||
91 | Ursodeoxycholic Acid Oral Suspension BP 125 mg | Each 5 ml contains: | |||
Ursodeoxycholic acid | IP | 125 | mg | ||
In a Flavoured base | |||||
Colour: Sunset Yellow FCF | |||||
Dosages : As directed by the physician. | |||||
92 | Potassoum Chloride Oral Solution USP | Each 15 ml contains: | |||
Potassium Chloride | IP | 1.5 | mg | ||
Flavoured Sorbitol 70% Base | |||||
(Each 15 ml will supply 20 milliequivalent of elemental potassium) | |||||
Colour : Sunset Yellow FCF | |||||
93 | Dextromethorphan hydrobromide,Ambroxol, | Each 5 ml contains: | |||
chlorpheniramine Maleate,Phenylephrine | Dextromethorphan Hydrobromide | IP | 10 | mg | |
Hydrochloride and Menthol Syrup | Ambroxol Hydrochloride | IP | 15 | mg | |
Chlorpheniramine Maleate | IP | 2 | mg | ||
Phenylephrine hydrochloride | IP | 5 | mg | ||
Menthol | IP | 1.5 | mg | ||
Flavoured Base | |||||
Colour: Ponceau 4R | |||||
Dosages : As directed by the physician. | |||||
94 | Cyproheptadine Hydrochloride and tricholine | Each ml contains: | |||
Citrate Drops | Cyproheptadine Hydrochloride | IP | 1.5 | mg | |
Tricholine Citrate | 55 | mg | |||
Flavoured Syrupy Sorbitol Base | |||||
Colour:- Caramel | |||||
Dosage: As directed by the Physician | |||||
Bon-Heur Pharmaceuticals Plot No. 131, Sector-6A, IIE, SIDCUL Haridwar (Uttarakhand)-249403 | |||||
Approved Product List (Oral Liquid) | |||||
NO. | GENERIC NAME | COMPOSITION | |||
95 | Cyproheptadine Hydrochloride,Tricholine and Sorbitol | Each 5 ml contains: | |||
Syrup | Cyproheptadine Hydrochloride | IP | 2 | mg | |
Tricholine Citrate | 275 | mg | |||
Sorbitol (70%) | 2 | gm | |||
(Non-crystallising) | |||||
Flavoured Syrupy Base | |||||
Colour:- Caramel | |||||
Dosage: As directed by the Physician | |||||
96 | Dextromethorphan Hydrobromide, Phenylephrine | Each 5 ml contains: | |||
Hydrochloride and Chlorpheniramine Maleate | Dextromethorphan Hydrobromide | IP | 10 | mg | |
and Menthol Syrup | Phenylephrine hydrochloride | IP | 5 | mg | |
Chlorpheniramine Maleate | IP | 2 | mg | ||
Menthol | IP | 1 | mg | ||
Flavoured Syrupy Base | |||||
Colour:- Brilliant Blue FCF & Tartrazine | |||||
Dosage: As directed by the Physician | |||||
97 | Sodium Alginate,Sodium Bicarbonate & Calcium | Each 5 ml contains: | |||
Carbonate Oral Suspention | Sodium Alginate | IP | 250 | mg | |
Sodium Bicarbonate | IP | 133.50 | mg | ||
Calcium Carbonate | IP | 80 | mg | ||
In a flavoured Suspension Base | |||||
Dosage: As directed by the Physician |
Contact Us
- BonHeur Pharmaceuticals Mfg. Unit: Plot No. 131, Sector- 6A, IIE SIDCUL, Ranipur (B.H.E.L.), Haridwar - (U.K.)-249403
- Office: +91 - 9520865925
- Email: info@bonheurpharma.com
- www.bonheurpharma.com